Firm Finds Novel Mechanism Of Action For HIV A Hard Sell For Investors
Executives at Koronis Pharmaceuticals are finding that having a drug with a new mechanism of action in the HIV space is a hurdle when seeking financing.
Executives at Koronis Pharmaceuticals are finding that having a drug with a new mechanism of action in the HIV space is a hurdle when seeking financing.